Abstract | BACKGROUND AND OBJECTIVE: PATIENTS AND METHODS: 69 patients with HHT were treated with APC and estriol nose ointment. 43 patients could be examined over a follow-up period of more than 20 months. The bleeding frequency and intensity as well as the patient's satisfaction with the treatment result were evaluated and the serum estriol level determined. RESULTS: After more than 20 months, the bleeding frequency and intensity were reduced in 95% of the patients compared to their preoperative findings. Under the influence of estriol, former berry-like telangiectasias became flatter and more even. Neither systemic side effects under topically applied estriol nor a relevant increase of serum estriol levels were observed. CONCLUSION: The combined treatment regimen with APC and topically applied estriol provides a new treatment concept of epistaxis in HHT.
|
Authors | H Sadick, F Riedel, J Oulmi, K Hörmann, W F Bergler |
Journal | HNO
(HNO)
Vol. 51
Issue 2
Pg. 118-24
(Feb 2003)
ISSN: 0017-6192 [Print] Germany |
Vernacular Title | Argonplasmachirurgie und topische Estriolapplikation. Langzeitergebnisse in der Behandlung von hereditären hämorrhagischen Teleangiektasien der Nasenschleimhaut. |
PMID | 12589417
(Publication Type: Evaluation Study, Journal Article)
|
Chemical References |
|
Topics |
- Administration, Topical
- Adolescent
- Adult
- Aged
- Aged, 80 and over
- Child
- Combined Modality Therapy
- Epistaxis
(genetics, therapy)
- Estriol
(administration & dosage)
- Female
- Follow-Up Studies
- Humans
- Laser Coagulation
- Male
- Middle Aged
- Nasal Mucosa
(blood supply)
- Patient Satisfaction
- Postoperative Care
- Telangiectasia, Hereditary Hemorrhagic
(genetics, therapy)
|